Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL

NCT06387121 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions

DRUG: Vincristine
DRUG: Cyclophosphamide
DRUG: Dexamethasone
DRUG: Venetoclax
DRUG: Inotuzumab ozogamicin
DRUG: Blinatumomab
DRUG: 6-mercaptopurine
DRUG: Methotrexate
DRUG: Cytarabine
DRUG: Prednisone

Sponsor

Institute of Hematology & Blood Diseases Hospital, China